Hoffmeister David F 4/A

What Happened

• David F. Hoffmeister, a director of Glaukos Corp (GKOS), received a grant of derivative awards on 2026-05-28 covering 2,987 shares. The grant is reported as an award (derivative instrument) with no cash paid at grant; the corrected exercise price is $106.52 per share. Exercising all options would require roughly $318,174 (2,987 × $106.52).
• This Form 4A amends a Form 4 filed June 1, 2026 to correct the exercise price (originally and incorrectly reported as $53.57). The award was granted under the issuer's Director Compensation Policy and vests in full one year after the grant date.

Key Details

• Transaction date: 2026-05-28; Amended Form 4A filed: 2026-06-23 (original Form 4 filed 2026-06-01).
• Award: 2,987 derivative shares (options); exercise price: $106.52 per share; reported acquisition price $0 (grant).
• Vesting: Vests in full on the one-year anniversary of the grant date (per company policy).
• Post-transaction holdings: Not specified in the provided excerpt.
• Footnotes: F1 corrects the exercise price to $106.52; F2 confirms grant under Director Compensation Policy and one-year vesting.
• Filing timeliness: Original Form 4 was filed June 1, 2026 (the amendment corrects the earlier reporting error); no late-filing indication in this amendment.

Context

• This was an equity award (options) to a director, not an open-market purchase or sale. The award does not indicate immediate sale of shares — the options vest in one year and would require exercising (and payment of the exercise price) to acquire shares.
• Grants to non-employee directors are common as compensation; they are informational but do not by themselves imply buying or selling behavior in the market.